Novo Nordisk $NVO announced that the company will buyback B shares for an amount up to DKK 3.4bn ($510mn) between the period of August 5 to October 26. The decision is a part of the broader repurchase program of up to DKK 14bn, to be completed during 12-month period, starting Feb. 2016.